Your browser doesn't support javascript.
loading
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies.
Wrapp, Daniel; Ye, Xiaohua; Ku, Zhiqiang; Su, Hang; Jones, Harrison G; Wang, Nianshuang; Mishra, Akaash K; Freed, Daniel C; Li, Fengsheng; Tang, Aimin; Li, Leike; Jaijyan, Dabbu Kumar; Zhu, Hua; Wang, Dai; Fu, Tong-Ming; Zhang, Ningyan; An, Zhiqiang; McLellan, Jason S.
  • Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
  • Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Su H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Jones HG; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
  • Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
  • Mishra AK; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
  • Freed DC; Merck Research Laboratories, Merck & Co. Inc., Kenilworth, NJ 07033, USA.
  • Li F; Merck Research Laboratories, Merck & Co. Inc., Kenilworth, NJ 07033, USA.
  • Tang A; Merck Research Laboratories, Merck & Co. Inc., Kenilworth, NJ 07033, USA.
  • Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Jaijyan DK; Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Zhu H; Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Wang D; Merck Research Laboratories, Merck & Co. Inc., Kenilworth, NJ 07033, USA.
  • Fu TM; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Sci Adv ; 8(10): eabm2546, 2022 Mar 11.
Article en En | MEDLINE | ID: mdl-35275718
ABSTRACT
Human cytomegalovirus (HCMV) encodes multiple surface glycoprotein complexes to infect a variety of cell types. The HCMV Pentamer, composed of gH, gL, UL128, UL130, and UL131A, enhances entry into epithelial, endothelial, and myeloid cells by interacting with the cell surface receptor neuropilin 2 (NRP2). Despite the critical nature of this interaction, the molecular determinants that govern NRP2 recognition remain unclear. Here, we describe the cryo-EM structure of NRP2 bound to Pentamer. The high-affinity interaction between these proteins is calcium dependent and differs from the canonical carboxyl-terminal arginine (CendR) binding that NRP2 typically uses. We also determine the structures of four neutralizing human antibodies bound to the HCMV Pentamer to define susceptible epitopes. Two of these antibodies compete with NRP2 binding, but the two most potent antibodies recognize a previously unidentified epitope that does not overlap the NRP2-binding site. Collectively, these findings provide a structural basis for HCMV tropism and antibody-mediated neutralization.